Pidotimod in paucisymptomatic SARS-CoV2 infected patients: Pidotimod in COVID-19. (2020). Mediterranean Journal of Hematology and Infectious Diseases, 12(1), e2020048. https://doi.org/10.4084/mjhid.2020.048